Dorais, Julie J.D., M.P.H.
"The Cost of Evidence: Examining the FDA's Treatment of Critically-Needed Drugs from an Ex Ante Perspective,"
North Carolina Central University Science & Intellectual Property Law Review: Vol. 8
, Article 2.
Available at: https://archives.law.nccu.edu/siplr/vol8/iss1/2